AcquisitionOther

PARDES BIOSCIENCES, INC. acquired target

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

PARDES BIOSCIENCES, INC. -> target · $2.13

(Merger Sub), has successfully completed the previously announced tender offer to acquire all of Pardes’ outstanding shares of common stock for a per share price of (i) $2.13 in cash (the Cash Amount), plus (ii) a non-tradeable contingent value right (each, a

Open source record (SEC) ↗